Login to Your Account


Investors worry that market correction will be lengthy

By Peter Winter

Monday, April 7, 2014

While a number of analysts report that their investors show no signs of panic after the late February meltdown in all biotech stocks, they remain nervous about the sector wondering if its tremendous performance over the past two years has finally come to an end. The two-day exodus from biotech certainly contributed to ugly returns in March.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription